A new study reveals how Staphylococcus aureus bacteria adopt a different diet when colonizing the lungs, suggesting a new treatment strategy for these often dangerous staph infections.
Researchers from the NIH RECOVER Initiative have identified long COVID symptoms in kids and teens, which could ultimately lead to improved diagnoses and treatments for millions.
A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A study involving Columbia researchers finds that malaria parasites in Africa have developed resistance to artemisinin drugs, which could worsen malaria’s impact if partner drugs fail in the future.
The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
At the award ceremony, the nation's top infectious disease expert spoke about his decades-long effort to end the HIV/AIDS crisis (see video in the article).
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.